Your browser doesn't support javascript.
loading
Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry.
Sakai, Ryoko; Cho, Soo-Kyung; Nanki, Toshihiro; Watanabe, Kaori; Yamazaki, Hayato; Tanaka, Michi; Koike, Ryuji; Tanaka, Yoshiya; Saito, Kazuyoshi; Hirata, Shintaro; Amano, Koichi; Nagasawa, Hayato; Sumida, Takayuki; Hayashi, Taichi; Sugihara, Takahiko; Dobashi, Hiroaki; Yasuda, Shinsuke; Sawada, Tetsuji; Ezawa, Kazuhiko; Ueda, Atsuhisa; Fujii, Takao; Migita, Kiyoshi; Miyasaka, Nobuyuki; Harigai, Masayoshi.
Affiliation
  • Sakai R; Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. sakai.phv@tmd.ac.jp.
  • Cho SK; Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. sakai.phv@tmd.ac.jp.
  • Nanki T; Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. aushalten@naver.com.
  • Watanabe K; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, 222 Wangsimni-ro, Seongdong-gu, Seoul, 133-791, South Korea. aushalten@naver.com.
  • Yamazaki H; Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. nanki.rheu@tmd.ac.jp.
  • Tanaka M; Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. nanki.rheu@tmd.ac.jp.
  • Koike R; Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. watanabe.rheu@tmd.ac.jp.
  • Tanaka Y; Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. watanabe.rheu@tmd.ac.jp.
  • Saito K; Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. yamazaki.rheu@tmd.ac.jp.
  • Hirata S; Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. yamazaki.rheu@tmd.ac.jp.
  • Amano K; Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. tanaka.phv@tmd.ac.jp.
  • Nagasawa H; Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. tanaka.phv@tmd.ac.jp.
  • Sumida T; Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. koike.rheu@tmd.ac.jp.
  • Hayashi T; Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. koike.rheu@tmd.ac.jp.
  • Sugihara T; Clinical Research Center, Tokyo Medical and Dental University Hospital, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. koike.rheu@tmd.ac.jp.
  • Dobashi H; The First Department of Internal medicine, University of Occupational and Environmental Health, 1-1, Iseigaoka, Kitakyushu Yahatanishi-ku, Fukuoka, 807-0804, Japan. tanaka@med.uoeh-u.ac.jp.
  • Yasuda S; The First Department of Internal medicine, University of Occupational and Environmental Health, 1-1, Iseigaoka, Kitakyushu Yahatanishi-ku, Fukuoka, 807-0804, Japan. kazu-s@med.uoeh-u.ac.jp.
  • Sawada T; The First Department of Internal medicine, University of Occupational and Environmental Health, 1-1, Iseigaoka, Kitakyushu Yahatanishi-ku, Fukuoka, 807-0804, Japan. s-hirata@med.uoeh-u.ac.jp.
  • Ezawa K; Department of Rheumatology/Clinical Immunology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe-shi, Saitama, 350-8550, Japan. amanokoi@saitama-med.ac.jp.
  • Ueda A; Department of Rheumatology/Clinical Immunology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe-shi, Saitama, 350-8550, Japan. nagasawa@saitama-med.ac.jp.
  • Fujii T; Division of Clinical Immunology, Doctoral Program in Clinical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, 305-0006, Japan. tsumida@md.tsukuba.ac.jp.
  • Migita K; Division of Clinical Immunology, Doctoral Program in Clinical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, 305-0006, Japan. taichi8.th@gmail.com.
  • Miyasaka N; Department of Rheumatology, Tokyo Metropolitan Geriatric Hospital, 35-2, Sakaecho, Itabashi-ku, Tokyo, 173-0015, Japan. takahiko_sugihara@tmghig.jp.
  • Harigai M; Department of Internal Medicine, Division of Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan. hdobashi@med.kagawa-u.ac.jp.
Arthritis Res Ther ; 17: 74, 2015 Mar 23.
Article in En | MEDLINE | ID: mdl-25880658
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Registries / Tumor Necrosis Factor-alpha / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Arthritis Res Ther Journal subject: REUMATOLOGIA Year: 2015 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Registries / Tumor Necrosis Factor-alpha / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Arthritis Res Ther Journal subject: REUMATOLOGIA Year: 2015 Document type: Article Affiliation country: